[{"address1": "2001 Market Street", "address2": "Suite 3915 Unit #15", "city": "Philadelphia", "state": "PA", "zip": "19103", "country": "United States", "phone": "267-225-7416", "website": "https://www.contexttherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Martin A. Lehr", "age": 40, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 765596, "exercisedValue": 0, "unexercisedValue": 27676}, {"maxAge": 1, "name": "Ms. Jennifer  Minai-Azary", "age": 46, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 564090, "exercisedValue": 0, "unexercisedValue": 15208}, {"maxAge": 1, "name": "Mr. Alex C. Levit Esq., J.D.", "age": 45, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 541334, "exercisedValue": 0, "unexercisedValue": 14582}, {"maxAge": 1, "name": "Mr. Christopher  Beck M.B.A.", "title": "Senior Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Dashnau M.B.A., Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen  Chagin M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.6552, "open": 0.6655, "dayLow": 0.6301, "dayHigh": 0.6776, "regularMarketPreviousClose": 0.6552, "regularMarketOpen": 0.6655, "regularMarketDayLow": 0.6301, "regularMarketDayHigh": 0.6776, "payoutRatio": 0.0, "beta": 1.859, "forwardPE": -2.2413793, "volume": 150407, "regularMarketVolume": 150407, "averageVolume": 249332, "averageVolume10days": 168290, "averageDailyVolume10Day": 168290, "bid": 0.4413, "ask": 0.849, "bidSize": 1, "askSize": 2, "marketCap": 58307728, "fiftyTwoWeekLow": 0.49, "fiftyTwoWeekHigh": 2.75, "fiftyDayAverage": 0.72124, "twoHundredDayAverage": 1.180975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -30384334, "profitMargins": 0.0, "floatShares": 39385523, "sharesOutstanding": 89704200, "sharesShort": 1724171, "sharesShortPriorMonth": 2274426, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.019199999, "heldPercentInsiders": 0.02325, "heldPercentInstitutions": 0.79933, "shortRatio": 5.09, "shortPercentOfFloat": 0.0233, "impliedSharesOutstanding": 89704200, "bookValue": 1.014, "priceToBook": 0.6410256, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -27634568, "trailingEps": -0.28, "forwardEps": -0.29, "enterpriseToEbitda": 0.961, "52WeekChange": -0.64402175, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 0.65, "targetHighPrice": 9.0, "targetLowPrice": 4.0, "targetMeanPrice": 5.4, "targetMedianPrice": 5.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 89352224, "totalCashPerShare": 0.996, "ebitda": -31617174, "totalDebt": 193706, "quickRatio": 47.024, "currentRatio": 48.802, "debtToEquity": 0.213, "returnOnAssets": -0.38009998, "returnOnEquity": -0.55588, "freeCashflow": -36900256, "operatingCashflow": -15224195, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CNTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1751389719, "exchange": "NCM", "messageBoardId": "finmb_408000800", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Context Therapeutics Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 249332, "fiftyTwoWeekLowChange": 0.15999997, "fiftyTwoWeekLowChangePercent": 0.32653055, "fiftyTwoWeekRange": "0.49 - 2.75", "fiftyTwoWeekHighChange": -2.1, "fiftyTwoWeekHighChangePercent": -0.76363635, "fiftyTwoWeekChangePercent": -64.402176, "earningsTimestamp": 1746648597, "earningsTimestampStart": 1746648597, "earningsTimestampEnd": 1746648597, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.28, "epsForward": -0.29, "epsCurrentYear": -0.214, "priceEpsCurrentYear": -3.037383, "fiftyDayAverageChange": -0.07124001, "fiftyDayAverageChangePercent": -0.098774344, "twoHundredDayAverageChange": -0.530975, "twoHundredDayAverageChangePercent": -0.4496073, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-20", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": -0.7936551, "regularMarketPrice": 0.65, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634736600000, "regularMarketChange": -0.0052000284, "regularMarketDayRange": "0.6301 - 0.6776", "longName": "Context Therapeutics Inc.", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]